CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Patients enrolled in the study will be randomized before surgery: in one study arm, the search for lymph node metastases in surgically removed sentin...
Rome, Italy, Italy
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...
Phase 2
Roma, Italy and 65 other locations
for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...
Phase 3
Rome, Italy and 77 other locations
study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...
Phase 3
Roma, Italy and 99 other locations
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
Roma, Italy and 243 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Roma, Italy and 243 other locations
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
Rome, Italy and 82 other locations
The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...
Phase 3
Rome, Italy and 190 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Rome, Italy and 168 other locations
global, multi-arm study to evaluate efficacy and safety of relacorilant in combination with other treatments in patients with gynecological cancers...
Phase 2
Rome, Italy and 44 other locations
Clinical trials
Research sites
Resources
Legal